Course Exam
301908 VO Development of novel cancer immunotherapies (2023S)
from target identification through target validation to clinical trials
Labels
WHEN?
Tuesday
05.03.2024
Examiners
Information
Assessment and permitted materials
Written exam, alternative: presentation
Minimum requirements and assessment criteria
Understanding of the basic mechanisms of resistance development and of newest technologies
Last modified: Tu 19.03.2024 16:06